NEPH MEXC RealStocks
Own real NEPH shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 19:10:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Nephros Inc. (NEPH) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3.03, with a market capitalization of $35.98M and a P/E ratio of 17.35. Over the past 52 weeks, its price has ranged from $2.66 to $6.42. This page covers its latest market performance, valuation, price trends and company information.
$35.98M | |
$3.21 | |
$3.29 | |
$3.03 | |
$3.31 | |
37.92K | |
44.78K | |
17.35 | |
$6.42 | |
$2.66 | |
-- | |
-- |
Nephros Inc. (NEPH) last closed at $3.03 as of 2026-11-14 00:31:00, down 6.65% ($0.22) from the previous close of $3.31.
During the latest regular trading session, NEPH traded between $3.03 and $3.29, with a volume of 37.92K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Nephros Inc. (NEPH) moved from $3.09 to $3.03, representing a decline of 2.04% ($0.06).
The stock traded between $2.72 and $3.43 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 92.34 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.7%
NEPH is currently trading at $3.03, placing it 9.7% of the way from its 52-week low of $2.66 to its 52-week high of $6.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 36 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nephros Inc. (NEPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NEPH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NEPH shares and USD.
NEPH Shares to USD
1.00 NEPH shares = 3.027 USD
Calculations are estimates based on the latest available price and are for reference only.